imatinib mesylate has been researched along with Depression in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, Y; Tian, X; Wang, C; Yu, B; Zhang, L; Zhang, X | 1 |
| Chang, J; Huang, T; Liang, X; Nan, K; Tu, H; Wang, Y; Wei, Y; Yang, T; Yuan, X; Zhou, F | 1 |
| Akker, M; Cevik, G; Demir, AM; Maden, M; Merev, E; Pamuk, GE; Umit, EG; Uyanik, MS; Uyanik, V | 1 |
| Blank, SD; Butrynski, JE; Corless, CL; Dressel, DM; Ebrahim, KS; Heinrich, MC; Hornick, JL; Long, KB | 1 |
| Jacobsen, PB; Jim, HS; Komrokji, R; Lancet, J; Lee, MR; Phillips, KM; Pinilla-Ibarz, J; Small, BJ; Sokol, L; Sotomayor, E; Sweet, K; Tinsley, S | 1 |
| Frantz, S | 1 |
6 other study(ies) available for imatinib mesylate and Depression
| Article | Year |
|---|---|
9.4 T static magnetic field ameliorates imatinib mesylate-induced toxicity and depression in mice.
Topics: Animals; Antineoplastic Agents; Body Weight; Depression; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Mice; Pyrimidines | 2023 |
Reactive Oxygen Species Are Involved in the Development of Gastric Cancer and Gastric Cancer-Related Depression through ABL1-Mediated Inflammation Signaling Pathway.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antineoplastic Agents; Behavior, Animal; Cell Line, Tumor; Cell Movement; Depression; Disease Models, Animal; Epithelial-Mesenchymal Transition; Humans; Imatinib Mesylate; Inflammation Mediators; Male; Mice; Mice, Nude; Prognosis; Proto-Oncogene Proteins c-abl; Reactive Oxygen Species; Signal Transduction; Stomach Neoplasms | 2019 |
The impact of new generic formulations of imatinib mesylate on general quality of life in chronic phase chronic myeloid leukaemia patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Anxiety; Depression; Diarrhea; Drugs, Generic; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Linear Models; Maintenance Chemotherapy; Male; Middle Aged; Multivariate Analysis; Protein Kinase Inhibitors; Quality of Life; Time Factors | 2017 |
Primary extragastrointestinal stromal tumor of the pleura: report of a unique case with genetic confirmation.
Topics: Anoctamin-1; Antineoplastic Agents; Atrial Fibrillation; Benzamides; Chloride Channels; Depression; Gastrointestinal Stromal Tumors; Humans; Hypercholesterolemia; Hypertension; Imatinib Mesylate; Immunohistochemistry; Male; Membrane Proteins; Middle Aged; Mutation; Neoplasm Proteins; Neoplasm Recurrence, Local; Piperazines; Pleural Neoplasms; Polymerase Chain Reaction; Proto-Oncogene Proteins c-kit; Pyrimidines | 2010 |
Quality of life outcomes in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a controlled comparison.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Benzamides; Case-Control Studies; Dasatinib; Depression; Fatigue; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Outcome Assessment, Health Care; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Quality of Life; Surveys and Questionnaires; Thiazoles; United States; Young Adult | 2013 |
Drug discovery: playing dirty.
Topics: Animals; Benzamides; Cardiovascular Diseases; Clinical Trials as Topic; Clozapine; Depression; Drug Approval; Drug Design; Drug Evaluation, Preclinical; Drug Industry; Gefitinib; Humans; Imatinib Mesylate; Neoplasms; Piperazines; Pyrimidines; Quinazolines; Sensitivity and Specificity; Substrate Specificity; Therapeutics; United States; United States Food and Drug Administration | 2005 |